Inventor
SAFO MARTIN K
SA24 patents
⚠️ This page may combine multiple inventors who share the name “SAFO MARTIN K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV KING ABDULAZIZ
18 patentsUS10836729B1Nov 17, 2020
Metabolically stable 5-HMF derivatives for the treatment of hypoxia
UNIV KING ABDULAZIZ4 citations80
US10836736B1Nov 17, 2020
Pharmaceutical composition with cytotoxic activity on colorectal cancer cells
UNIV KING ABDULAZIZ7 citations80
US11325885B2May 10, 2022
Method for treating stomach cancer
UNIV KING ABDULAZIZ1 citations72
US11312680B2Apr 26, 2022
Method for treating a patient having a colon cancer
UNIV KING ABDULAZIZ1 citations72
US11214537B2Jan 4, 2022
Method for making anti-cancer compounds
UNIV KING ABDULAZIZ1 citations72
US11142493B1Oct 12, 2021
Pharmaceutical composition for treating cancer
UNIV KING ABDULAZIZ1 citations72
US11136288B2Oct 5, 2021
Method for treating a patient having cancer
UNIV KING ABDULAZIZ1 citations72
US10988439B2Apr 27, 2021
Cytotoxic compounds, pharmaceutical compositions thereof, and methods of treating cancer
UNIV KING ABDULAZIZ1 citations72
US11319292B2May 3, 2022
Metabolically stable 5-HMF derivatives for the treatment of hypoxia
UNIV KING ABDULAZIZ1 citations69
US10709662B1Jul 14, 2020
Mucoadhesive buccal film having a dual release carrier system
UNIV KING ABDULAZIZ2 citations68
US10653634B1May 19, 2020
Polymeric nanoparticulate formulation to enhance the oral bioavailability of dapoxetine
UNIV KING ABDULAZIZ2 citations68
US11312694B2Apr 26, 2022
Method for making propenamide compound
UNIV KING ABDULAZIZ0 citations59
US11214556B1Jan 4, 2022
Method of treating colorectal cancer
UNIV KING ABDULAZIZ0 citations59
US11155528B2Oct 26, 2021
Bis-propenamide compounds and methods of treating cancer
UNIV KING ABDULAZIZ0 citations59
US11149012B1Oct 19, 2021
Metabolically stable 5-HMF derivatives for the treatment of hypoxia
UNIV KING ABDULAZIZ0 citations58
US11104632B1Aug 31, 2021
Metabolically stable vanillin derivatives for the treatment of hypoxia
UNIV KING ABDULAZIZ1 citations58
US11458144B1Oct 4, 2022
Methods for using 5-HMF analogs with increased solubility to inhibit or reverse RBC sickling
UNIV KING ABDULAZIZ0 citations56
US10844007B1Nov 24, 2020
Amide group-containing compounds and use for cancer treatment
UNIV KING ABDULAZIZ0 citations51
UNIV VIRGINIA COMMONWEALTH
5 patentsUS9765017B2Sep 19, 2017
Allosteric hemoglobin modifiers with nitric oxide releasing moiety
UNIV VIRGINIA COMMONWEALTH4 citations69
US10875834B2Dec 29, 2020
Prodrug and protected forms of 5-hydroxymethylfurfuranal (5-HMF) and its derivatives
UNIV VIRGINIA COMMONWEALTH2 citations68
US10344001B2Jul 9, 2019
Azolylacryloyl derivatives as therapeutic agents for sickle cell disease
UNIV VIRGINIA COMMONWEALTH3 citations67
US7119208B2Oct 10, 2006
Anti-sickling agents
UNIV VIRGINIA COMMONWEALTH5 citations61
US11401241B2Aug 2, 2022
Aromatic aldehydes with sustained and enhanced in vitro and in vivo pharmacologic activity to treat sickle cell disease
UNIV VIRGINIA COMMONWEALTH0 citations54